No Data
No Data
Lukang Biochemical: 2024 Annual Performance Forecast
Lifecome Biochemistry (002868.SZ): Expected loss for the year 2024 is between 0.34 billion yuan and -0.39 billion yuan.
According to Gelonghui on January 23, Lifecome Biochemistry (002868.SZ) announced its performance forecast for 2024, expecting revenue of 0.64 billion yuan to -0.65 billion yuan; the Net income attributable to the shareholders of the listed company is estimated to be a loss of 0.39 billion yuan to 0.34 billion yuan, a decrease of 75.82% to 53.28% compared to the same period last year; the Net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses is projected to be a loss of 0.395 billion yuan to 0.345 billion yuan, a decrease of 71.16% to 49.49% compared to the same period last year; the basic EPS is expected to be a loss of 2.51 yuan/share to 2.19 yuan/share. Revenue compared to the same period last year.
The Recent Pullback Must Have Dismayed Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Insiders Who Own 37% of the Company
Lifecome Biochemistry (002868.SZ): plans to transfer 9.7768% equity of Pucheng Rural Credit Cooperatives to Putan Thermal Energy.
On December 10, Gelonghui reported that Lifecome Biochemistry (002868.SZ) announced that it held the eighth (temporary) meeting of the fifth Board of Directors and the seventh meeting of the fifth Board of Supervisors on December 9, 2024. They reviewed and approved the proposal regarding the sale of part of the equity of the Rural Credit Cooperative of Pucheng County to optimize the company's asset structure, improve the quality of external investments, and enhance the company's ongoing operational capacity. The Board of Directors agreed to transfer the 9.7768% equity (hereinafter referred to as the 'symbol equity') held in the Rural Credit Cooperative of Pucheng County (hereinafter referred to as 'Pucheng Rural Credit') to Fujian Putan.
Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Shares Fly 25% But Investors Aren't Buying For Growth
Lukang Biochemical: Report for the third quarter of 2024